Alastin Skincare Announces Appointment of Amber Edwards as Chief Commercial Officer

August 4, 2020

Alastin Skincare Inc.—a specialty aesthetics company dedicated to developing and marketing innovative, clinically tested, physician-dispensed skin care products with proprietary TriHex Technology that enhance, protect and maintain healthy skin for a lifetime—has announced the appointment of Amber Edwards to the position of chief commercial officer, effective July 31, 2020.
Edwards holds a proven track record of successful business leadership and global development of leading brands in the medical aesthetics arena. She most recently served as president of North America for Sinclair Pharma. Prior to Sinclair, she was at Allergan Inc., where she was the vice president of international strategic marketing, Medical Aesthetics Franchise, in the U.K. She also has experience with Allergan in the U.S., in both aesthetic and therapeutic areas. Edwards began her career in sales and marketing roles at Pfizer.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical
    • Botox Cosmetic’s “The Confidence Collective” to Empower 250 Women Entrepreneurs
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement